Contact this trialFirst, we need to learn more about you.
PD-1 Inhibitor
Tazemetostat + Topotecan + Pembrolizumab for Small Cell Lung Cancer
Recruiting1 awardPhase 1
Bethesda, Maryland
This trial is testing a combination of drugs to treat small cell lung cancer that has come back after a period of treatment. The drugs work in different ways to stop the growth of tumor cells. The combination of these drugs may shrink or stabilize the cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.